Fosfomycin Resistance Evolutionary Pathways of


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 Jan 2022
Historique:
received: 16 12 2021
revised: 13 01 2022
accepted: 14 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 11 3 2022
Statut: epublish

Résumé

The rise of multidrug-resistant Gram-negative pathogens and the lack of novel antibiotics to address this problem has led to the rescue of old antibiotics without a relevant use, such as fosfomycin.

Identifiants

pubmed: 35163052
pii: ijms23031132
doi: 10.3390/ijms23031132
pmc: PMC8835530
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Fosfomycin 2N81MY12TE
Carbon 7440-44-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : RD16/0016/0011
Organisme : Comunidad de Madrid
ID : S2017/BMD-3691
Organisme : MCIN/AEI /10.13039/501100011033
ID : PID2020-113521RB-I00

Références

Int J Mol Sci. 2021 Dec 23;23(1):
pubmed: 35008587
Nat Rev Microbiol. 2010 Apr;8(4):260-71
pubmed: 20208551
Trends Microbiol. 2010 May;18(5):205-14
pubmed: 20202847
Antimicrob Agents Chemother. 2018 Oct 24;62(11):
pubmed: 30104274
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Clin Microbiol Rev. 2012 Jan;25(1):2-41
pubmed: 22232370
mBio. 2020 May 26;11(3):
pubmed: 32457248
Cell. 2007 Sep 7;130(5):797-810
pubmed: 17803904
J Bacteriol. 1992 Sep;174(17):5748-52
pubmed: 1512209
J Bacteriol. 2003 Feb;185(4):1218-28
pubmed: 12562791
Infect Immun. 2013 Sep;81(9):3210-9
pubmed: 23774603
J Biol Chem. 2003 Sep 12;278(37):35193-8
pubmed: 12842882
J Biol Chem. 2002 Sep 27;277(39):36697-705
pubmed: 12119303
Indian J Crit Care Med. 2018 Jul;22(7):533-536
pubmed: 30111930
Biochemistry. 1996 Apr 16;35(15):4923-8
pubmed: 8664284
BMC Microbiol. 2009 Jul 13;9:136
pubmed: 19594901
J Biol Chem. 2004 Oct 22;279(43):45102-9
pubmed: 15304478
Microbiology (Reading). 2008 Dec;154(Pt 12):3905-3916
pubmed: 19047757
ACS Omega. 2020 Feb 04;5(7):3271-3281
pubmed: 32118142
Clin Microbiol Rev. 2016 Apr;29(2):321-47
pubmed: 26960938
Front Microbiol. 2017 Aug 31;8:1511
pubmed: 28912755
Mol Microbiol. 1993 Jan;7(1):69-79
pubmed: 8094880
Antimicrob Agents Chemother. 1992 Apr;36(4):826-9
pubmed: 1503445
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29038268
Nature. 2017 Sep 14;549(7671):233-237
pubmed: 28869968
J Biol Chem. 1998 May 15;273(20):12466-75
pubmed: 9575204
Pharmacotherapy. 2015 Oct;35(10):949-62
pubmed: 26497481
Nat Rev Microbiol. 2015 Jan;13(1):42-51
pubmed: 25435309
Clin Infect Dis. 2008 Apr 1;46(7):1069-77
pubmed: 18444827
Front Microbiol. 2016 Sep 30;7:1551
pubmed: 27746770
Arch Intern Med. 1996 Feb 26;156(4):433-5
pubmed: 8607729
Mol Microbiol. 1996 Jun;20(6):1221-33
pubmed: 8809774
mSystems. 2020 Jun 2;5(3):
pubmed: 32487742
FEMS Microbiol Rev. 2011 Sep;35(5):768-89
pubmed: 21645016
J Microbiol Biotechnol. 2012 Apr;22(4):484-93
pubmed: 22534295
Antimicrob Agents Chemother. 2004 Jun;48(6):2274-6
pubmed: 15155232
Antimicrob Agents Chemother. 2002 Jun;46(6):1793-9
pubmed: 12019092
PLoS Pathog. 2019 Sep 12;15(9):e1007651
pubmed: 31513674
Microbiology (Reading). 1994 May;140 ( Pt 5):1035-43
pubmed: 8025669
J Bacteriol. 2001 Feb;183(3):1032-7
pubmed: 11208802
Trends Microbiol. 1994 Mar;2(3):76-81
pubmed: 8156275
PLoS One. 2011;6(9):e25573
pubmed: 21984934
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Braz J Microbiol. 2016 Apr-Jun;47(2):381-8
pubmed: 26991296
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4124-9
pubmed: 17289841
mBio. 2019 Jul 9;10(4):
pubmed: 31289173
Antimicrob Agents Chemother. 1990 May;34(5):844-8
pubmed: 2193621
Essays Biochem. 2017 Mar 3;61(1):37-48
pubmed: 28258228
Antimicrob Agents Chemother. 1984 May;25(5):539-44
pubmed: 6375560
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Semin Respir Crit Care Med. 2015 Apr;36(2):225-35
pubmed: 25826590
FEBS Lett. 2006 Feb 13;580(4):1042-8
pubmed: 16337944
Mol Microbiol. 2013 May;88(3):473-85
pubmed: 23517463
Mol Microbiol. 2009 May;72(4):978-94
pubmed: 19400808
mSystems. 2021 Dec 21;6(6):e0105521
pubmed: 34846167
Expert Rev Anti Infect Ther. 2020 Apr;18(4):335-347
pubmed: 32052662
J Biol Chem. 1995 Mar 3;270(9):4822-39
pubmed: 7876255
Front Microbiol. 2017 Aug 28;8:1590
pubmed: 28894437
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Clin Microbiol Infect. 2012 Jan;18(1):4-7
pubmed: 21914036
Antimicrob Agents Chemother. 2003 Sep;47(9):2850-8
pubmed: 12936984
J Antibiot (Tokyo). 1975 Nov;28(11):906-11
pubmed: 1104551

Auteurs

Teresa Gil-Gil (T)

Programa de Doctorado en Biociencias Moleculares, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Centro Nacional de Biotecnología, CSIC, Darwin 3, 28049 Madrid, Spain.

José L Martínez (JL)

Centro Nacional de Biotecnología, CSIC, Darwin 3, 28049 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH